Needham & Company
View Older Stories
-
Aerie Pharmaceuticals to Participate in the 20th Annual Needham Virtual Healthcare Conference
-
Companies with NDRs 08/13
-
Companies with NDRs 08/12
-
Aerie Pharmaceuticals to Present at the Needham Virtual Healthcare Conference
-
Aerie Pharma (AERI) PT Lowered to $48 at Needham & Company
-
Aerie Pharma (AERI) Management NDR Addresses Guidance Revision - Needham
-
Companies with NDRs 09/17
-
Aerie Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference
-
Aerie Pharma (AERI) Named Top Pick for 2019 at Needham & Company
-
Aerie Pharma (AERI) PT Raised to $86 at Needham & Company Following Investor Meeting
-
Aerie Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference
-
Aerie Pharma (AERI) PT Raised to $76 at Needham & Company
-
Aerie Pharma (AERI): Raising PT On Roclatan Data - Needham
-
Aerie Pharma (AERI): Notes From Company Non Deal Roadshow - Needham
-
Aerie Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference
-
Aerie Pharma (AERI) PT Raised to $58 at Needham & Company on 4Q EPS/Revenue Beats; 'Rhopressa NDA Refiled'
-
Aerie Pharma (AERI): Another Delay But Not Product Related - Needham
-
Aerie Pharma (AERI) PT Raised to $52 at Needham & Company as Roclatan Knocks It Out of the Park
-
Aerie Pharma (AERI): Reiterating Buy Ahead Of 2 Major Catalysts - Needham
-
Aerie Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference
-
Aerie Pharma (AERI) PT Raised to $45 at Needham & Company
-
Needham & Company Upgrades Aerie Pharma (AERI) to Buy
-
Needham & Company Downgrades Aerie Pharma (AERI) to Hold
-
Aerie Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference
-
Aerie Pharma (AERI) PT Raised to $37 at Needham & Company
-
Aerie Pharma (AERI) Target Lifted to $26 at Needham & Company
-
Aerie Pharma (AERI) Target Price Lifted to $22 at Needham & Company Following Data
-
After Serious Outperformace in 2013, Needham & Company Lays Out 2014's Top Stock Picks
-
Needham & Company Starts Aerie Pharma (AERI) at Buy
-
Aerie Pharmaceuticals (AERI) IPO Opens Modestly Higher

